Test Price
2,800 AED✅ Home Collection Available
WDR11 Gene Hypogonadotropic Hypogonadism Type 14 Genetic Test in UAE
Executive Summary & Core Metrics
The WDR11 gene analysis offers 99.9% diagnostic sensitivity for hypogonadotropic hypogonadism type 14, conducted under ISO 9001:2015 accredited processes. Our service includes VIP mobile phlebotomy with temperature‑controlled cold‑chain transport, complimentary telephonic post‑test genetic counselling, and direct insurance billing verification via WhatsApp.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited next‑generation sequencing.
- Premium Logistics: VIP mobile phlebotomy & temperature‑controlled cold‑chain home collection (daily 8 AM–11 PM).
- Clinical Guidance: Complimentary telephonic post‑test result interpretation by a board‑registered genetic counsellor.
- Insurance Made Easy: Direct billing verification and pre‑approval assistance via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The WDR11 gene test uses next‑generation sequencing (NGS) to detect pathogenic and likely pathogenic variants associated with hypogonadotropic hypogonadism type 14. This autosomal recessive disorder delays or prevents normal puberty and impairs fertility. Early molecular diagnosis enables targeted hormonal therapy and reproductive planning.
| Feature | Our NGS WDR11 Test | Alternative (Sanger Sequencing) |
|---|---|---|
| Analytical Sensitivity | 99.9% | ~95% |
| Method | Next‑generation sequencing (full gene coverage) | Single‑gene dideoxy sequencing |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Clinical Report | ACMG‑classified variant interpretation & genetic counselling summary | Basic mutation confirmation only |
Physician Insight & Safety Protocols
“WDR11‑related hypogonadotropic hypogonadism is a treatable condition when identified early. A positive genetic result should never be interpreted in isolation; correlation with endocrine profiles, imaging, and family history is essential. I strongly encourage every patient to discuss findings with their endocrinologist or clinical geneticist to personalise the management plan.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory & Medication Precautions
⚠️ Important Medication Warning
Do not discontinue any prescribed hormonal therapy, gonadotropin injections, or other medications without explicit instruction from your treating doctor. Abrupt cessation can lead to serious metabolic or reproductive consequences.
Exclusion Criteria & Emergency Red Flags
- Active febrile illness (≥38.5 °C) or systemic infection – reschedule after full recovery.
- Blood transfusion or bone marrow transplant within the last 14 days may interfere with DNA analysis.
- Pregnant individuals: genetic counselling is mandatory; fetal sampling is not part of this test.
🚨 Seek emergency care immediately if you experience: sudden severe headache, acute vision changes, extreme abdominal pain, or loss of consciousness – these rarely relate to the test but require urgent medical evaluation.
Patient FAQ & Clinical Guidance
1. What is the purpose of the WDR11 gene test?
This test confirms a diagnosis of hypogonadotropic hypogonadism type 14 by detecting pathogenic variants in the WDR11 gene. It helps guide fertility treatments, hormone replacement therapy, and genetic counselling for affected individuals and families.
2. How is the sample collected and what is the turnaround time?
A standard blood draw (or buccal swab, if preferred) is collected at your home by a DHA‑licensed phlebotomist using our VIP mobile service. Results are reported within 3–4 weeks from sample receipt.
3. Is this test covered by insurance in the UAE?
Most UAE health insurers cover diagnostic genetic testing when deemed medically necessary. We assist with direct billing verification and pre‑approval via WhatsApp – contact us at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Legal Compliance
All personal and genetic data is processed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical procedures and patient consent follow the guidelines of Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Our laboratory holds DHA Facility License No. 1143 and operates under the corporate name DNA Labs UAE at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | WDR11 Gene Sequencing – Hypogonadotropic Hypogonadism Type 14 |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood or buccal swab (non‑invasive) |
| Methodology Used | Next‑generation sequencing (NGS), full gene coverage |
| ICD‑10‑CM Code | E23.0 (Hypogonadotropic hypogonadism) |
| LOINC Code | 81222‑9 (WDR11 gene mutation analysis) |
| DHA Facility License & Address | License #1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians